PMC:7796052 / 16251-16506 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7796052","sourcedb":"PMC","sourceid":"7796052","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7796052","text":"Present results support previous claims suggesting the use of raloxifene based on its capacity to inhibit the IL-6/STAT3 signaling pathway [45], and also for being a prospective antiviral agent for SARS-Cov2 as inhibitor of the two-pore channel TCP2 [48].","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"415","span":{"begin":110,"end":114},"obj":"Gene"},{"id":"416","span":{"begin":115,"end":120},"obj":"Gene"},{"id":"417","span":{"begin":198,"end":207},"obj":"Species"},{"id":"419","span":{"begin":62,"end":72},"obj":"Chemical"}],"attributes":[{"id":"A415","pred":"tao:has_database_id","subj":"415","obj":"Gene:3569"},{"id":"A416","pred":"tao:has_database_id","subj":"416","obj":"Gene:6774"},{"id":"A417","pred":"tao:has_database_id","subj":"417","obj":"Tax:2697049"},{"id":"A419","pred":"tao:has_database_id","subj":"419","obj":"MESH:D020849"},{"subj":"415","pred":"source","obj":"LitCovid-PubTator"},{"subj":"416","pred":"source","obj":"LitCovid-PubTator"},{"subj":"417","pred":"source","obj":"LitCovid-PubTator"},{"subj":"419","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T113","span":{"begin":0,"end":255},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T113","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#eca993","default":true},{"id":"LitCovid-sentences","color":"#9397ec"}]}]}}